Identification and characterization of calcium binding protein, spermatid-associated 1 (CABS1)# in selected human tissues and fluids.

Calcium binding protein, spermatid associated 1 (CABS1) is a protein most widely studied in spermatogenesis. However, mRNA for CABS1 has been found in numerous tissues, albeit with little information about the protein. Previously, we identified CABS1 mRNA and protein in human salivary glands and provided evidence that in humans CABS1 contains a heptapeptide near its carboxyl terminus that has anti-inflammatory activities.

Structural and posttranslational analysis of human calcium-binding protein, spermatid-associated 1.

Recently, we detected a novel biomarker in human saliva called calcium-binding protein, spermatid-associated 1 (CABS1). CABS1 protein had previously been described only in testis, and little was known of its characteristics other than it was considered a structurally disordered protein. Levels of human CABS1 (hCABS1) in saliva correlate with stress, whereas smaller sized forms of hCABS1 in saliva are associated with resilience to stress.

Histologic and histomorphometric evaluation of an allograft stem cell-based matrix sinus augmentation procedure.

Purpose: Long-term success of dental implants has been demonstrated when placed simultaneously with or after a sinus augmentation procedure. However, optimal bone formation can be from 6 to 9 months or longer with grafting materials other than autogenous bone. For this reason, there is interest in any surgical technique that does not require autogenous bone harvesting, yet results in sufficient bone formation within a relatively short time frame.

Histologic evaluation of a stem cell-based sinus-augmentation procedure.

Background: Predictability has been demonstrated for the long-term success of dental implants placed simultaneously with or after a sinus-augmentation procedure. However, the time required to obtain optimal bone formation can be from 6 to 9 months or longer with grafting materials other than autogenous bone. For this reason, there is interest in a surgical technique that does not require the harvest of autogenous bone but still results in sufficient bone formation within a relatively short time frame.

Elevation of the maxillary sinus floor with hydraulic pressure.

This study describes a new method using hydraulic pressure to elevate the antral floor for bone grafting between the sinus floor and the schneiderian membrane before placement of endosseous osseointegrated implants. The method was first modeled experimentally in hen eggs, acting as a surrogate sinus, and then in human cadaver preparations. Several clinical case reports are also presented.

A 6-year prospective study of 620 stress-diversion surface (SDS) dental implants.

A 6-year prospective study was conducted to assess the clinical success rates and crestal bone response of a dental implant system with a stress-diversion design. Mathematical modeling, digital radiography with applied isodensity, and finite element analysis were used to highlight the effect of the stress distribution design. A total of 386 hydroxyapatite-coated prototypes and 234 commercial grit-blasted external hex implants were placed in virgin bone as well as various grafted maxillary regions, with 36% of the posterior implants being immediately loaded.

A prospective, multicenter, 4-year study of the ACE Surgical resorbable blast media implant.

This article reports on the 50-month results of the evaluation of the ACE Surgical resorbable blast media (RBM) dental implant. There were 1077 implants placed in 348 patients: 950 in the mandible and 127 in the maxilla. A total of 78.

Technique for producing platelet-rich plasma and platelet concentrate: background and process.

Autologous platelet-rich plasma is a source of platelet-derived growth factor (PDGF) and transforming growth factor beta (TGF-beta), both important in accelerating hard and soft tissue maturation. This article describes a two-step centrifugation method to sequester and concentrate platelets to a level four to eight times baseline whole blood values. The technique produces concentrations of PDGF-AB above 500% and TGF-beta1 greater than 800%.